Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225740 · ClinicalTrials.gov registry record · NA

Exposure Therapy Consortium (ETC) for Anxiety Sensitivity

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
399
Enrollment target

NCT05225740 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 399 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05225740, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
399 participants
Enrollment target

Study Summary

The current study seeks to test differences between a single-session large-group format of standard exposure, enhanced exposure, and a control condition in treating anxiety sensitivity. It is hypothesized that 1) participants assigned to either exposure condition will evidence greater reductions in anxiety sensitivity from pre-treatment to posttreatment relative to those in the control condition; 2) participants assigned to the enhanced exposure condition will evidence greater reductions in anxiety sensitivity from pre-treatment to posttreatment relative to those in the standard exposure condition. The investigators will test putative moderators and mechanisms of action. Prior to initiating the study for purposes of data analyses, the investigators will pilot study procedures during Spring 2020.

Interventions

  • BEHAVIORAL Stress Management Training
  • BEHAVIORAL Standard Exposure
  • BEHAVIORAL Enhanced Exposure

Trial Details

FieldValue
Enrollment Target 399 participants
Start Date 2022-10-01
Est. Completion 2024-07-01
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT05225740

The ClinicalTrials.gov registry entry for NCT05225740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Stress Management Training is the first listed.

NCT05225740 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05225740 about?

NCT05225740 is a clinical study titled "Exposure Therapy Consortium (ETC) for Anxiety Sensitivity". The current study seeks to test differences between a single-session large-group format of standard exposure, enhanced exposure, and a control condition in treating anxiety sensitivity. It is hypothesized that 1) participants assigned to either exposure condition will evidence greater reductions in ...

What is the current status of trial NCT05225740?

This trial is currently completed. It is a NA study. The enrollment target is 399 participants. The study started on 2022-10-01. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT05225740?

The interventions under investigation include: Stress Management Training (BEHAVIORAL), Standard Exposure (BEHAVIORAL), Enhanced Exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT05225740?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.